Intensity Therapeutics, Inc. Common stock (INTS) — Defensive Interval Ratio
Intensity Therapeutics, Inc. Common stock (INTS) has a Defensive Interval Ratio of 0 days as of December 2024. Defensive assets of $0.00 (cash $-, short-term investments $0.00, receivables $-) cover 0 days of daily cash needs of $4.81K/day. See working capital to net assets of Intensity Therapeutics, Inc. Common stoc to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Intensity Therapeutics, Inc. Common stock Defensive Interval Ratio (2019–2024)
This chart shows how Intensity Therapeutics, Inc. Common stock's Defensive Interval Ratio has evolved across 6 annual periods from 2019 to 2024. As of December 2024, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. See Intensity Therapeutics, Inc. Common stoc (INTS) net asset quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Intensity Therapeutics, Inc. Common stock (2019–2024)
The table below presents the year-by-year Defensive Interval Ratio for Intensity Therapeutics, Inc. Common stock from 2019 to 2024, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see INTS market cap overview.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 0 days | $0.00 | $4.81K/day | $- | $0.00 | ▼ -573 days |
| 2023 | 573 days | $6.22 Million | $10.85K/day | $- | $6.22 Million | ▲ +570 days |
| 2022 | 3 days | $62.30K | $18.68K/day | $- | $0.00 | ▼ -2 days |
| 2021 | 5 days | $51.26K | $10.19K/day | $- | $- | ▼ -8 days |
| 2020 | 13 days | $48.52K | $3.69K/day | $- | $0.00 | ▼ -1475 days |
| 2019 | 1488 days | $4.60 Million | $3.09K/day | $- | $4.56 Million | — |